v3.25.1
FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS (Tables)
9 Months Ended
Mar. 31, 2025
FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS  
Schedule of financial assets measured at fair value on a recurring basis

The following tables present information about the Company’s financial assets measured at fair value on a recurring basis and indicates the fair value hierarchy classification as of March 31, 2025 and June 30, 2024 (in thousands):

Fair Value Measurement of Assets as of March 31, 2025

Total

Level 1

Level 2

Level 3

Cash and cash equivalents:

Money market funds

$

7,695

$

7,695

$

$

Corporate commercial paper

3,496

3,496

Marketable debt securities:

Corporate commercial paper

18,456

18,456

U.S. Government agencies

4,943

4,943

U.S. Government treasuries

Corporate notes and bonds

50,411

50,411

Total

$

85,001

$

7,695

$

77,306

$

Fair Value Measurement of Assets as of June 30, 2024

Total

Level 1

Level 2

Level 3

Cash and cash equivalents:

Money market funds

$

61,249

$

61,249

$

$

Marketable debt securities:

Corporate commercial paper

20,929

20,929

U.S. Government agencies

1,997

1,997

U.S. Government treasuries

2,720

2,720

Corporate notes and bonds

30,832

30,832

Asset-backed securities

263

263

Total

$

117,990

$

61,249

$

56,741

$

Schedule of changes in the fair value of the company's derivative liabilities, fair value, level 3 inputs

The following table sets forth changes in the fair value of the Company’s liabilities for which fair value was determined on a recurring basis for the nine months ended March 31, 2025 and 2024 (in thousands):

2025

2024

Warrant

Embedded

 

Warrant

Embedded

Fair value, beginning of period

$

$

468

$

$

412

Warrant liability incurred on March 8, 2024

5,697

Changes in fair value

15

1,950

41

Fair value, end of period

$

$

483

$

7,647

$

453